<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35447067</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1080-6059</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emerging infectious diseases</Title>
          <ISOAbbreviation>Emerg Infect Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018.</ArticleTitle>
        <Pagination>
          <StartPage>967</StartPage>
          <EndPage>976</EndPage>
          <MedlinePgn>967-976</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3201/eid2805.211958</ELocationID>
        <Abstract>
          <AbstractText>Bordetella pertussis not expressing pertactin has increased in countries using acellular pertussis vaccines (ACV). The deficiency is mostly caused by pertactin gene disruption by IS481. To assess the effect of the transition from whole-cell vaccine to ACV on the emergence of B. pertussis not expressing pertactin in Spain, we studied 342 isolates collected during 1986-2018. We identified 93 pertactin-deficient isolates. All were detected after introduction of ACV and represented 38% of isolates collected during the ACV period; 58.1% belonged to a genetic cluster of isolates carrying the unusual prn::del(-292, 1340) mutation. Pertactin inactivation by IS481 insertion was identified in 23.7% of pertactin-deficient isolates, arising independently multiple times and in different phylogenetic branches. Our findings support the emergence and dissemination of a cluster of B. pertussis with an infrequent mechanism of pertactin disruption in Spain, probably resulting from introduction of ACV.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mir-Cros</LastName>
            <ForeName>Alba</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moreno-Mingorance</LastName>
            <ForeName>Albert</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martín-Gómez</LastName>
            <ForeName>M Teresa</ForeName>
            <Initials>MT</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abad</LastName>
            <ForeName>Raquel</ForeName>
            <Initials>R</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bloise</LastName>
            <ForeName>Iván</ForeName>
            <Initials>I</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Campins</LastName>
            <ForeName>Magda</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>González-Praetorius</LastName>
            <ForeName>Alejandro</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gutiérrez</LastName>
            <ForeName>M Nieves</ForeName>
            <Initials>MN</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martín-González</LastName>
            <ForeName>Héctor</ForeName>
            <Initials>H</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Muñoz-Almagro</LastName>
            <ForeName>Carmen</ForeName>
            <Initials>C</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Orellana</LastName>
            <ForeName>M Ángeles</ForeName>
            <Initials>MÁ</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Pablos</LastName>
            <ForeName>Manuela</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roca-Grande</LastName>
            <ForeName>Josep</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodrigo</LastName>
            <ForeName>Carlos</ForeName>
            <Initials>C</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodríguez</LastName>
            <ForeName>M Elena</ForeName>
            <Initials>ME</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Uriona</LastName>
            <ForeName>Sonia</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vidal</LastName>
            <ForeName>M José</ForeName>
            <Initials>MJ</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pumarola</LastName>
            <ForeName>Tomàs</ForeName>
            <Initials>T</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Larrosa</LastName>
            <ForeName>M Nieves</ForeName>
            <Initials>MN</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>González-López</LastName>
            <ForeName>Juan José</ForeName>
            <Initials>JJ</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Emerg Infect Dis</MedlineTA>
        <NlmUniqueID>9508155</NlmUniqueID>
        <ISSNLinking>1080-6040</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001425">Bacterial Outer Membrane Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010567">Pertussis Vaccine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010566">Virulence Factors, Bordetella</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>63GD90PP8X</RegistryNumber>
          <NameOfSubstance UI="C068929">pertactin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001425" MajorTopicYN="N">Bacterial Outer Membrane Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001886" MajorTopicYN="Y">Bordetella pertussis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010567" MajorTopicYN="N">Pertussis Vaccine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010566" MajorTopicYN="N">Virulence Factors, Bordetella</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014917" MajorTopicYN="Y">Whooping Cough</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Bordetella pertussis</Keyword>
        <Keyword MajorTopicYN="Y">Spain</Keyword>
        <Keyword MajorTopicYN="Y">bacteria</Keyword>
        <Keyword MajorTopicYN="Y">pertussis vaccine</Keyword>
        <Keyword MajorTopicYN="Y">phylogenetic evolution</Keyword>
        <Keyword MajorTopicYN="Y">virulence factors</Keyword>
        <Keyword MajorTopicYN="Y">whooping cough</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>21</Day>
          <Hour>20</Hour>
          <Minute>11</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35447067</ArticleId>
        <ArticleId IdType="pmc">PMC9045434</ArticleId>
        <ArticleId IdType="doi">10.3201/eid2805.211958</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>van Gent M, Heuvelman CJ, van der Heide HG, Hallander HO, Advani A, Guiso N, et al.
Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012.
Eur J Clin Microbiol Infect Dis. 2015;34:821–30. 10.1007/s10096-014-2297-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-014-2297-2</ArticleId>
            <ArticleId IdType="pmc">PMC4365279</ArticleId>
            <ArticleId IdType="pubmed">25527446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Octavia S, Sintchenko V, Gilbert GL, Lawrence A, Keil AD, Hogg G, et al.
Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010.
J Infect Dis. 2012;205:1220–4. 10.1093/infdis/jis178</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jis178</ArticleId>
            <ArticleId IdType="pubmed">22416243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mir-Cros A, Moreno-Mingorance A, Martín-Gómez MT, Codina G, Cornejo-Sánchez T, Rajadell M, et al.
Population dynamics and antigenic drift of Bordetella pertussis following whole cell vaccine replacement, Barcelona, Spain, 1986-2015.
Emerg Microbes Infect. 2019;8:1711–20. 10.1080/22221751.2019.1694395</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/22221751.2019.1694395</ArticleId>
            <ArticleId IdType="pmc">PMC6882445</ArticleId>
            <ArticleId IdType="pubmed">31769735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barkoff A-M, Mertsola J, Pierard D, Dalby T, Hoegh SV, Guillot S, et al.
Surveillance of circulating Bordetella pertussis strains in Europe during 1998-2015.
J Clin Microbiol. 2018;56:e01998–17. 10.1128/JCM.01998-17</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.01998-17</ArticleId>
            <ArticleId IdType="pmc">PMC5925733</ArticleId>
            <ArticleId IdType="pubmed">29491017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N. First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.
Vaccine. 2009;27:6034–41. 10.1016/j.vaccine.2009.07.074</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2009.07.074</ArticleId>
            <ArticleId IdType="pubmed">19666155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeddeman A, van Gent M, Heuvelman CJ, van der Heide HG, Bart MJ, Advani A, et al.
Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012.
Euro Surveill. 2014;19:20881. 10.2807/1560-7917.ES2014.19.33.20881</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2807/1560-7917.ES2014.19.33.20881</ArticleId>
            <ArticleId IdType="pubmed">25166348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Otsuka N, Han H-J, Toyoizumi-Ajisaka H, Nakamura Y, Arakawa Y, Shibayama K, et al.
Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.
PLoS One. 2012;7:e31985. 10.1371/journal.pone.0031985</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0031985</ArticleId>
            <ArticleId IdType="pmc">PMC3279416</ArticleId>
            <ArticleId IdType="pubmed">22348138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lam C, Octavia S, Ricafort L, Sintchenko V, Gilbert GL, Wood N, et al.
Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.
Emerg Infect Dis. 2014;20:626–33. 10.3201/eid2004.131478</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2004.131478</ArticleId>
            <ArticleId IdType="pmc">PMC3966384</ArticleId>
            <ArticleId IdType="pubmed">24655754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pawloski LC, Queenan AM, Cassiday PK, Lynch AS, Harrison MJ, Shang W, et al.
Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.
Clin Vaccine Immunol. 2014;21:119–25. 10.1128/CVI.00717-13</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CVI.00717-13</ArticleId>
            <ArticleId IdType="pmc">PMC3910938</ArticleId>
            <ArticleId IdType="pubmed">24256623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Safarchi A, Octavia S, Luu LDW, Tay CY, Sintchenko V, Wood N, et al.
Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model.
Vaccine. 2015;33:6277–81. 10.1016/j.vaccine.2015.09.064</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2015.09.064</ArticleId>
            <ArticleId IdType="pubmed">26432908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barkoff A-M, He Q. Molecular epidemiology of Bordetella pertussis.
Adv Exp Med Biol. 2019;1183:19–33. 10.1007/5584_2019_402</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/5584_2019_402</ArticleId>
            <ArticleId IdType="pubmed">31342459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouchez V, Guillot S, Landier A, Armatys N, Matczak S, Toubiana J, et al.; French pertussis microbiology study group. Evolution of Bordetella pertussis over a 23-year period in France, 1996 to 2018.
Euro Surveill. 2021;26:2001213. 10.2807/1560-7917.ES.2021.26.37.2001213</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.37.2001213</ArticleId>
            <ArticleId IdType="pmc">PMC8447829</ArticleId>
            <ArticleId IdType="pubmed">34533118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barkoff A-M, Mertsola J, Pierard D, Dalby T, Hoegh SV, Guillot S, et al.
Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015.
Euro Surveill. 2019;24:1700832. 10.2807/1560-7917.ES.2019.24.7.1700832</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2807/1560-7917.ES.2019.24.7.1700832</ArticleId>
            <ArticleId IdType="pmc">PMC6381657</ArticleId>
            <ArticleId IdType="pubmed">30782265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weigand MR, Williams MM, Peng Y, Kania D, Pawloski LC, Tondella ML; CDC Pertussis Working Group. Genomic survey of Bordetella pertussis diversity, United States, 2000–2013.
Emerg Infect Dis. 2019;25:780–3. 10.3201/eid2504.180812</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2504.180812</ArticleId>
            <ArticleId IdType="pmc">PMC6433035</ArticleId>
            <ArticleId IdType="pubmed">30882317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barkoff A-M, Guiso N, Guillot S, Xing D, Markey K, Berbers G, et al.
A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines.
J Immunol Methods. 2014;408:142–8. 10.1016/j.jim.2014.06.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jim.2014.06.001</ArticleId>
            <ArticleId IdType="pubmed">24925807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsang RSW, Sill ML, Advani A, Xing D, Newland P, Hallander H. Use of monoclonal antibodies to serotype Bordetella pertussis isolates: comparison of results obtained by indirect whole-cell enzyme-linked immunosorbent assay and bacterial microagglutination methods.
J Clin Microbiol. 2005;43:2449–51. 10.1128/JCM.43.5.2449-2451.2005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.43.5.2449-2451.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1153803</ArticleId>
            <ArticleId IdType="pubmed">15872280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heikkinen E, Xing DK, Ölander R-M, Hytönen J, Viljanen MK, Mertsola J, et al.
Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
BMC Microbiol. 2008;8:162. 10.1186/1471-2180-8-162</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2180-8-162</ArticleId>
            <ArticleId IdType="pmc">PMC2562373</ArticleId>
            <ArticleId IdType="pubmed">18816412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weigand MR, Peng Y, Cassiday PK, Loparev VN, Johnson T, Juieng P, et al.
Complete genome sequences of Bordetella pertussis isolates with novel pertactin-deficient deletions.
Genome Announc. 2017;5:e00973–17. 10.1128/genomeA.00973-17</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/genomeA.00973-17</ArticleId>
            <ArticleId IdType="pmc">PMC5597764</ArticleId>
            <ArticleId IdType="pubmed">28912323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weigand MR, Peng Y, Loparev V, Batra D, Bowden KE, Burroughs M, et al.
The history of Bordetella pertussis genome evolution includes structural rearrangement.
J Bacteriol. 2017;199:e00806–16. 10.1128/JB.00806-16</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00806-16</ArticleId>
            <ArticleId IdType="pmc">PMC5370423</ArticleId>
            <ArticleId IdType="pubmed">28167525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hiramatsu Y, Miyaji Y, Otsuka N, Arakawa Y, Shibayama K, Kamachi K. Significant decrease in pertactin-deficient Bordetella pertussis isolates, Japan.
Emerg Infect Dis. 2017;23:699–701. 10.3201/eid2304.161575</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2304.161575</ArticleId>
            <ArticleId IdType="pmc">PMC5367402</ArticleId>
            <ArticleId IdType="pubmed">28322702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin SW, Pawloski L, Williams M, Weening K, DeBolt C, Qin X, et al.
Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.
Clin Infect Dis. 2015;60:223–7. 10.1093/cid/ciu788</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciu788</ArticleId>
            <ArticleId IdType="pubmed">25301209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zomer A, Otsuka N, Hiramatsu Y, Kamachi K, Nishimura N, Ozaki T, et al.
Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines.
Microb Genom. 2018;4:e000180. 10.1099/mgen.0.000180</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mgen.0.000180</ArticleId>
            <ArticleId IdType="pmc">PMC5994715</ArticleId>
            <ArticleId IdType="pubmed">29771235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyaji Y, Otsuka N, Toyoizumi-Ajisaka H, Shibayama K, Kamachi K. Genetic analysis of Bordetella pertussis isolates from the 2008-2010 pertussis epidemic in Japan.
PLoS One. 2013;8:e77165. 10.1371/journal.pone.0077165</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0077165</ArticleId>
            <ArticleId IdType="pmc">PMC3790747</ArticleId>
            <ArticleId IdType="pubmed">24124606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centro Nacional de Epidemiología, Instituto de Salud Carlos III. Situación de la Tosferina en España, 1998-2016 [cited 2022 Jan 30]. https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/archivos%20A-Z/TOSFERINA/Situación%20de%20la%20Tosferina%20en%20España,%201998-2016.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Polak M, Zasada AA, Mosiej E, Krysztopa-Grzybowska K, Witkowski L, Rzeczkowska M, et al.
Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.
Microbes Infect. 2019;21:170–5. 10.1016/j.micinf.2018.12.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.micinf.2018.12.001</ArticleId>
            <ArticleId IdType="pubmed">30580013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Safarchi A, Octavia S, Nikbin VS, Lotfi MN, Zahraei SM, Tay CY, et al.
Genomic epidemiology of Iranian Bordetella pertussis: 50 years after the implementation of whole cell vaccine.
Emerg Microbes Infect. 2019;8:1416–27. 10.1080/22221751.2019.1665479</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/22221751.2019.1665479</ArticleId>
            <ArticleId IdType="pmc">PMC6764348</ArticleId>
            <ArticleId IdType="pubmed">31543006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carriquiriborde F, Regidor V, Aispuro PM, Magali G, Bartel E, Bottero D, et al.
Rare detection of Bordetella pertussis pertactin-deficient strains in Argentina.
Emerg Infect Dis. 2019;25:2048–54. 10.3201/eid2511.190329</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2511.190329</ArticleId>
            <ArticleId IdType="pmc">PMC6810201</ArticleId>
            <ArticleId IdType="pubmed">31625838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Z, Octavia S, Luu LDW, Payne M, Timms V, Tay CY, et al.
Pertactin-negative and filamentous hemagglutinin-negative Bordetella pertussis, Australia, 2013–2017.
Emerg Infect Dis. 2019;25:1196–9. 10.3201/eid2506.180240</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2506.180240</ArticleId>
            <ArticleId IdType="pmc">PMC6537726</ArticleId>
            <ArticleId IdType="pubmed">31107218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kastrin T, Barkoff A-M, Paragi M, Vitek MG, Mertsola J, He Q. High prevalence of currently circulating Bordetella pertussis isolates not producing vaccine antigen pertactin in Slovenia.
Clin Microbiol Infect. 2019;25:258–60. 10.1016/j.cmi.2018.10.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmi.2018.10.005</ArticleId>
            <ArticleId IdType="pubmed">30691616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elomaa A, Advani A, Donnelly D, Antila M, Mertsola J, Hallander H, et al.
Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years.
J Clin Microbiol. 2005;43:3681–7. 10.1128/JCM.43.8.3681-3687.2005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.43.8.3681-3687.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1233997</ArticleId>
            <ArticleId IdType="pubmed">16081896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gorringe AR, Vaughan TE. Bordetella pertussis fimbriae (Fim): relevance for vaccines.
Expert Rev Vaccines. 2014;13:1205–14. 10.1586/14760584.2014.930667</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/14760584.2014.930667</ArticleId>
            <ArticleId IdType="pubmed">25102891</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
